Ustekinumab - NDC Database

8 records found
Page:1
57894-440 Apr 01, 2025
Ustekinumab 45 mg/.5ml Subcutaneous Injection, Solution by Janssen Biotech, Inc.
57894-441 Apr 01, 2025
Ustekinumab 90 mg/ml Subcutaneous Injection, Solution by Janssen Biotech, Inc.
57894-444 Apr 01, 2025
Ustekinumab 130 mg/26ml Intravenous Solution by Janssen Biotech, Inc.
65219-862 Nov 15, 2025
Ustekinumab-aauz-aauz 45 mg/.5ml Subcutaneous Injection, Solution by Fresenius Kabi USA, LLC
65219-866 Nov 15, 2025
Ustekinumab-aauz-aauz 90 mg/ml Subcutaneous Injection, Solution by Fresenius Kabi USA, LLC
82009-160 Apr 15, 2025
Ustekinumab-ttwe-ttwe 45 mg/.5ml Subcutaneous Injection, Solution by Quallent Pharmaceuticals Health LLC
82009-162 Apr 15, 2025
Ustekinumab-ttwe-ttwe 90 mg/ml Subcutaneous Injection, Solution by Quallent Pharmaceuticals Health LLC
82009-163 Apr 15, 2025
Ustekinumab-ttwe-ttwe 130 mg/26ml Intravenous Injection, Solution by Quallent Pharmaceuticals Health LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.